Meenakshi Mission Becomes First Hospital in India to Treat GFAP Astrocytopathy, a Rare Autoimmune Disease – MMHRC
March 10, 2025
GFAP astrocytopathy, first defined in 2016, can cause rapid changes in both physical and mental health. Diagnosing it is a challenge, as its symptoms mimic those of an array of infectious/inflammatory conditions of the brain and the spinal cord.
In a first in India, Meenakshi Mission Hospital and Research Centre, a leading multispecialty hospital in south Tamil Nadu, successfully treated a 31-year old female who was diagnosed with autoimmune GFAP astrocytopathy, a rare and recently-defined autoimmune disease that affects the functions of the brain and the spinal cord. Following a 10-day treatment given recently involving intravenous antibiotics and steroids, the patient had a complete cure and was discharged.
Event Date: April 16th, 2026 Event Title: Press Meet - A Rare Spine Complication, A Remarkable Comeback! Event Description: A Rare Spine Complication, A Remarkable Comeback! Doctors at Madurai Meenakshi...
Event Date: March 7th, 2026 Event Title: MIDCON 2026 Event Description: MIDCON 2026 - Organized by the Infection Prevention and Control Committee of Meenakshi Mission Hospital and Research Centre and...
Event Date: February 26th, 2026 Event Title: Times Business Awards – Madurai & Trichy 2026 Event Description: Doctors from Madurai Meenakshi Mission Hospital and Research Centre were honoured at the...
